Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1
- 1 May 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9318) , 1667-1668
- https://doi.org/10.1016/s0140-6736(02)08557-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Chloroquine Exerts an Additive in Vitro Anti-HIV Type 1 Effect When Associated with Didanosine and HydroxyureaAIDS Research and Human Retroviruses, 1999
- Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1Clinical Therapeutics, 1997
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Inhibition of Human Immunodeficiency Virus Type 1 Replication by Hydroxychloroquine in T Cells and MonocytesAIDS Research and Human Retroviruses, 1993